Jeffrey Kadanoff
Chief Financial Officer at GHGSAT
Greater Montreal Metropolitan Area
Overview
Work Experience
Chief Financial Officer
2024 - Current
Managing Director
2019 - 2024
Esplanade Ventures is an early-stage digital health venture fund.
Interim Chief Financial Officer
2020 - 2022
Chief Financial Officer / Consultant
2018 - 2019
Chief Financial Officer
2017 - 2018
One of the most innovative consumer healthcare and beauty companies in North America.
Raised $10,000,000.00 from Knight Therapeutics.
Chief Financial Officer
2014 - 2017
Knight Therapeutics Inc. is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets.
Strategy Consulltant
2013 - 2014
Advise on strategic planning, market feasibility and growth strategy for clients such as Cirque du Soleil, Edipresse and Paladin Labs.
Vice President - Strategic Planning and Development
2011 - 2013
Reporting to the COO, manage a group of 25 employees, as head of strategy for specialty apparel retailer with over $1B in sales. Responsibilities include strategic planning, mergers & acquisitions, corporate development, ecommerce development, customer insights and strategic partnerships.
Principal
1997 - 2011
Collaborate as a trusted advisor with clients’ VPs and C-level executives to drive strategic change and operational improvements. Responsible for strategy, project management, senior client relationships and team management.
Process Engineer
1994 - 1997
Develop several large scale chemical processing plants. Perform key engineering duties ranging from capital and operating cost estimates, equipment design and selection, and plant start-up procedures.
Education
MBA with Distinction
2003 - 2004
B. Eng.
1990 - 1994